Making sense of China’s R&D ascent
With an uptick in licensing deals and promising data emerging from China-based biopharmas, especially in oncology, it’s clear the country is poised to play a major role in life sciences for the forese...
25 Heinä 202536min
AI, mentorship and finding your voice in pharma marketing
In this episode of "The Top Line," Ayla Ellison, Editor-in-Chief of Fierce Life Sciences and Healthcare, sits down with two longtime industry leaders to talk about what it takes to stand out and grow ...
18 Heinä 202513min
Biopharma layoffs aren't letting up
Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025. In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Par...
11 Heinä 202510min
Peter Pitts talks FDA direction, industry communication (Sponsored)
In the latest episode of the Health Matters podcast, Wendy Lund sits down with Peter Pitts, former FDA associate commissioner and current president of the Center for Medicine in the Public Interest, t...
8 Heinä 202524min
